The interaction between BM‐MSCs and OS cells is bidirectional: the mesenchymal stroma activated by tumour cells secrete higher levels of IL‐6, IL‐8, GRO‐α and MCP‐1 in the tumour microenvironment. This evidence concerns the gene CCL2 and neoplasm.